Shareholder alert: robbins llp informs investors of class action against immunitybio, inc. (ibrx)

San diego--(business wire)---- $ibrx #anktiva--immunitybio, inc. (ibrx) misled investors regarding the viability and efficacy of its drug candidate.

IBRX Ratings Summary

IBRX Quant Ranking